**Core Concept**
The question is testing the understanding of tumour suppressor genes and their role in cancer development. **BRCA1 and BRCA2** are key tumour suppressor genes that, when mutated, increase the risk of breast and ovarian cancer.

**Why the Correct Answer is Right**
The correct answer is a mutation in the **BRCA2 gene**. BRCA2 is a large gene that provides instructions for making a protein called breast cancer type 2 susceptibility protein. This protein plays a crucial role in repairing damaged DNA and, when mutated, can lead to chromosomal instability and cancer. The BRCA2 protein helps to repair double-strand breaks in DNA by recruiting other proteins that help to repair the damage. Mutations in the BRCA2 gene can lead to a deficiency in this repair process, increasing the risk of breast and ovarian cancer.

**Why Each Wrong Option is Incorrect**
* **Option A:** This option is incorrect because it does not mention a specific tumour suppressor gene. While there are many genes involved in cancer development, the question specifically asks for a mutation in a tumour suppressor agent that causes breast carcinoma.
* **Option B:** This option is incorrect because it does not specify a tumour suppressor gene. While there are many genes involved in cancer development, the question specifically asks for a mutation in a tumour suppressor agent that causes breast carcinoma.
* **Option D:** This option is incorrect because it does not mention a specific tumour suppressor gene. While there are many genes involved in cancer development, the question specifically asks for a mutation in a tumour suppressor agent that causes breast carcinoma.

**Clinical Pearl / High-Yield Fact**
It is essential to remember that mutations in the **BRCA1 and BRCA2 genes** are responsible for a significant proportion of hereditary breast and ovarian cancer cases. These mutations can be inherited in an autosomal dominant pattern, meaning that a single copy of the mutated gene is sufficient to increase the risk of cancer.

**Correct Answer: C. A mutation in the BRCA2 gene.**